Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 66

Biotechnology

Researchers wirelessly recorded human brain activity during normal life activities
Biotechnology | Life Science History

Researchers wirelessly recorded human brain activity during normal life activities

On May 3, 2021, the National Institutes of Health announced that researchers wre able to wirelessly record the…

Read More Researchers wirelessly recorded human brain activity during normal life activitiesContinue

University of British Columbia researchers unveiled first molecular images of B.1.1.7 COVID-19 mutation
Biotechnology | Diagnostics

University of British Columbia researchers unveiled first molecular images of B.1.1.7 COVID-19 mutation

On May 3, 2021, University of British Columbia (UBC) researchers were the first in the world to publish…

Read More University of British Columbia researchers unveiled first molecular images of B.1.1.7 COVID-19 mutationContinue

Precipio launched Rapid COVID-19 Antibody test on Amazon platform
Biotechnology | COVID-19 | Diagnostics | FDA

Precipio launched Rapid COVID-19 Antibody test on Amazon platform

On May 3, 2021, Precipio announced that it had successfully launched its COVID-19 rapid antibody test (20 minute)…

Read More Precipio launched Rapid COVID-19 Antibody test on Amazon platformContinue

Moderna announced supply agreement with Gavi for up to 500 million doses of COVID-19 Vaccine Moderna for COVAX
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced supply agreement with Gavi for up to 500 million doses of COVID-19 Vaccine Moderna for COVAX

On May 3, 2021, Moderna announced an agreement with Gavi, the Vaccine Alliance to supply up to 500…

Read More Moderna announced supply agreement with Gavi for up to 500 million doses of COVID-19 Vaccine Moderna for COVAXContinue

Novavax initiated pediatric expansion for phase 3 clinical trial of COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax initiated pediatric expansion for phase 3 clinical trial of COVID-19 vaccine

On May 3, 2021, Novavax announced that it had initiated a pediatric expansion of its Phase 3 clinical…

Read More Novavax initiated pediatric expansion for phase 3 clinical trial of COVID-19 vaccineContinue

Moderna announced Emergency Use listing granted by the WHO for its COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine | WHO

Moderna announced Emergency Use listing granted by the WHO for its COVID-19 vaccine

On Apr. 30, 2021, Moderna announced that the World Health Organization (WHO) had issued Emergency Use Listing (EUL)…

Read More Moderna announced Emergency Use listing granted by the WHO for its COVID-19 vaccineContinue

Lonza and Moderna entered agreement to double drug substance production for COVID-19 vaccine in Visp
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Lonza and Moderna entered agreement to double drug substance production for COVID-19 vaccine in Visp

On Apr. 29, 2021, Lonza announced the expansion of its collaboration with Moderna to manufacture the drug substance…

Read More Lonza and Moderna entered agreement to double drug substance production for COVID-19 vaccine in VispContinue

Baby’s first poop predicted risk of developing allergies
Biotechnology | Diagnostics | Life Science History

Baby’s first poop predicted risk of developing allergies

On Apr. 29, 2021, researchers at the University of British Columbia (UBC) announced a study published in Cell…

Read More Baby’s first poop predicted risk of developing allergiesContinue

Large collaboration created cell atlas of COVID-19 pathology
Biotechnology | COVID-19 | Genomics | Non-Profit Research

Large collaboration created cell atlas of COVID-19 pathology

On Apr. 29, 2021, scientists from several hospitals and research centers reported what happens in individual cells of…

Read More Large collaboration created cell atlas of COVID-19 pathologyContinue

Moderna announced an increased global supply for COVID-19 vaccine to up to 3 billion doses in 2022
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced an increased global supply for COVID-19 vaccine to up to 3 billion doses in 2022

On Apr. 29, 2021, Moderna announced it was making new funding commitments to increase supply at its owned…

Read More Moderna announced an increased global supply for COVID-19 vaccine to up to 3 billion doses in 2022Continue

Biotechnology | COVID-19 | Pharmaceutical | Therapeutics | Vaccine

Pfizer and BioNTech submitted request to expand conditional marketing authorization of COMIRNATY in EU to adolescents

On Apr. 29, 2021, Pfizer and BioNTech announced they had submitted a variation to the Conditional Marketing Authorization…

Read More Pfizer and BioNTech submitted request to expand conditional marketing authorization of COMIRNATY in EU to adolescentsContinue

Scientists released error-free genomes of 25 animals with another 70,000 coming up
Biotechnology | Genomics | Non-Profit Research

Scientists released error-free genomes of 25 animals with another 70,000 coming up

On Apr. 28, 2021, Rockefeller University researchers announced the launch the Vertebrate Genomes Project, an ambitious initiative launched…

Read More Scientists released error-free genomes of 25 animals with another 70,000 coming upContinue

COVID-19 science and reason
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | Life Science History | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | USDA | Vaccine | WHO

COVID-19 science and reason

COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…

Read More COVID-19 science and reasonContinue

Moderna announced agreement with Sanofi for manufacturing of Moderna COVID-19 Vaccine in the U.S.
Biotechnology | COVID-19 | Disease | Infectious Disease | Oncology | Rare Disease | Therapeutics | Vaccine

Moderna announced agreement with Sanofi for manufacturing of Moderna COVID-19 Vaccine in the U.S.

On Apr. 26, 2021, Moderna announced that it had entered into an agreement with Sanofi for fill/finish sterile…

Read More Moderna announced agreement with Sanofi for manufacturing of Moderna COVID-19 Vaccine in the U.S.Continue

INOVIO planned for ex-US global phase 3 trial for INO-4800
Biotechnology | COVID-19 | Vaccine

INOVIO planned for ex-US global phase 3 trial for INO-4800

On Apr. 23, 2021, Inovio Pharma announced that it was planning for a predominantly ex-U.S. Phase 3 trial…

Read More INOVIO planned for ex-US global phase 3 trial for INO-4800Continue

Moderna announced new COVID-19 vaccine supply agreement with Israel for 2022
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced new COVID-19 vaccine supply agreement with Israel for 2022

On Apr. 20, 2021, Moderna announced a new supply agreement with Israel for 2022 whereby Israel also retained…

Read More Moderna announced new COVID-19 vaccine supply agreement with Israel for 2022Continue

Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics | Vaccine

Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATY

On Apr. 19, 2021, Pfizer and BioNTech announced supplying an additional 100 million doses of COMIRNATY, the companies…

Read More Pfizer and BioNTech to supply the European Union with 100 million additional doses of COMIRNATYContinue

Broad Institute expanded COVID-19 viral sequencing efforts for variant surveillance in the Northeast
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

Broad Institute expanded COVID-19 viral sequencing efforts for variant surveillance in the Northeast

On Apr. 19, 2021, the Broad Institute of MIT in partnership with the Centers for Disease Control and…

Read More Broad Institute expanded COVID-19 viral sequencing efforts for variant surveillance in the NortheastContinue

Mayo Clinic study found colon cancer driven by hereditary gene mutations in 1 in 6 patients
Biotechnology | Disease | Genomics | Therapeutics

Mayo Clinic study found colon cancer driven by hereditary gene mutations in 1 in 6 patients

On Apr. 19, 2021, the Mayo Clinic announced a study that bolstered evidence that colorectal cancer is often…

Read More Mayo Clinic study found colon cancer driven by hereditary gene mutations in 1 in 6 patientsContinue

Tonix Pharma entered worldwide licensing agreement to develop antiviral SARS-CoV-2 inhibitor for treatment of COVID-19
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Tonix Pharma entered worldwide licensing agreement to develop antiviral SARS-CoV-2 inhibitor for treatment of COVID-19

On Apr. 19, 2021, Tonix Pharmaceuticals and OyaGen announced an exclusive worldwide licensing agreement for an antiviral inhibitor…

Read More Tonix Pharma entered worldwide licensing agreement to develop antiviral SARS-CoV-2 inhibitor for treatment of COVID-19Continue

Texas A&M lab identified new COVID-19 variant; genome suggested potential resistance to antibodies
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Therapeutics

Texas A&M lab identified new COVID-19 variant; genome suggested potential resistance to antibodies

On Apr. 19, 2021, scientists at the Texas A&M University Global Health Research Complex (GHRC) announced they had…

Read More Texas A&M lab identified new COVID-19 variant; genome suggested potential resistance to antibodiesContinue

CytoDyn submitted Most Crucial Section of interim order to Health Canada for COVID-19 under rolling review
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

CytoDyn submitted Most Crucial Section of interim order to Health Canada for COVID-19 under rolling review

On Apr. 19, 2021, CytoDyn announced it had submitted the manufacturing section (CMC) of the application for an…

Read More CytoDyn submitted Most Crucial Section of interim order to Health Canada for COVID-19 under rolling reviewContinue

researchers discovered a gene that causes the most common form of muscular dystrophy in adults
Biotechnology | Disease | Therapeutics

researchers discovered a gene that causes the most common form of muscular dystrophy in adults

On Apr. 15. 2021, a team of researchers led by the University of Minnesota Medical School announced they…

Read More researchers discovered a gene that causes the most common form of muscular dystrophy in adultsContinue

Merck discontinued development of MK-7110 for COVID-19
Biotechnology | COVID-19 | Pharmaceutical | Vaccine

Merck discontinued development of MK-7110 for COVID-19

On Apr. 15, 2021, Merck announced the discontinuation of development of MK-7110 (formerly known as CD24Fc) for the…

Read More Merck discontinued development of MK-7110 for COVID-19Continue

Risk of rare blood clotting higher for COVID-19 than for vaccines
Biotechnology | COVID-19 | Vaccine

Risk of rare blood clotting higher for COVID-19 than for vaccines

On Apr. 15, 2021, researchers at the University of Oxford reported that the risk of the rare blood…

Read More Risk of rare blood clotting higher for COVID-19 than for vaccinesContinue

NIH funded new influenza research network
Biotechnology | Infectious Disease | Influenza | NIH | Therapeutics | Vaccine

NIH funded new influenza research network

On Apr. 15, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had had established…

Read More NIH funded new influenza research networkContinue

INOVIO’s COVID-19 vaccine candidate provided broad cross-reactive immune responses In humans against variants
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO’s COVID-19 vaccine candidate provided broad cross-reactive immune responses In humans against variants

On Apr. 15, 2021, Inovio Pharmaceuticals announced the results of a study focusing on the human immune responses…

Read More INOVIO’s COVID-19 vaccine candidate provided broad cross-reactive immune responses In humans against variantsContinue

CytoDyn executed agreement with Chiral Pharma to provide up to 200,000 vials of leronlimab to Philippines
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

CytoDyn executed agreement with Chiral Pharma to provide up to 200,000 vials of leronlimab to Philippines

On Apr. 15, 2021, CytoDyn announced it had executed an exclusive supply and distribution agreement with Chiral Pharma…

Read More CytoDyn executed agreement with Chiral Pharma to provide up to 200,000 vials of leronlimab to PhilippinesContinue

Alternating vaccines trial expanded to include two additional vaccines
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Alternating vaccines trial expanded to include two additional vaccines

On Apr. 14, 2021, researchers running the Com-Cov study, launched in February to investigate alternating doses of the…

Read More Alternating vaccines trial expanded to include two additional vaccinesContinue

Moderna announced clinical progress from mRNA Vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced clinical progress from mRNA Vaccine

On Apr. 14, 2021, Moderna announced that results from a preclinical study of the Company’s COVID-19 variant-specific vaccine…

Read More Moderna announced clinical progress from mRNA VaccineContinue

Page navigation

Previous PagePrevious 1 … 64 65 66 67 68 … 171 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search